Development of a quantitative biochemical and cellular sphingomyelin synthase assay using mass spectrometry

Analytical Biochemistry

Volumn 438, Issue 1, 2013, Pages 61-66

  Chen, Yanqun ^a   Yurek, David A ^a   Yu, Lan ^a   Wang, He ^a   Ehsani, Mariam E ^a   Qian, Yue Wei ^a   Konrad, Robert J ^a   Jiang, Xian Cheng ^b   Kuo, Ming Shang ^a   Cao, Guoqing ^a,c   Wang, Jian ^a  

^a ELI LILLY AND COMPANY   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c Hengrui Research and Development   (China)

Author keywords

Sphingomyelin Mass spectrometry Assay

Indexed keywords

BIOCHEMISTRY; MASS SPECTROMETRY;

CELLULAR EXTRACTS; OVER-EXPRESSION; QUANTITATIVE MEASUREMENT; SPECIFIC INHIBITORS; SPHINGOLIPIDS; SPHINGOMYELIN; SPHINGOMYELIN SYNTHASES; SUBCELLULAR LOCALIZATIONS;

PHOSPHOLIPIDS;

CELL EXTRACT; SPHINGOMYELIN; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE;

ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 84877042483     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2013.03.016     Document Type: Article

References (12)

1. K. Huitema, J. van den Dikkenberg, J.F. Brouwers, and J.C. Holthuis Identification of a family of animal sphingomyelin synthases EMBO J. 23 2004 33 44
2. F.G. Tafesse, P. Ternes, and J.C.M. Holthuis The multigenic sphingomyelin synthase family J. Biol. Chem. 281 2006 29421 29425
3. C. Luberto, and Y.A. Hannun Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation J. Biol. Chem. 273 1998 14550 14559
4. F.G. Tafesse, K. Huitema, M. Hermansson, S. van der Poel, J. van den Dikkenberg, A. Uphoff, P. Somerharju, and J.C. Holthuis Both sphingomyelin synthases SMS1 and SMS2 are required for sphingomyelin homeostasis and growth in human HeLa cells J. Biol. Chem. 282 2007 17537 17547
5. J. Dong, J. Liu, B. Lou, Z. Li, X. Ye, M. Wu, and X.C. Jiang Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice J. Lipid Res. 47 2006 1307 1314
6. N. Yan, T. Ding, J. Dong, Y. Li, and M. Wu Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells Lipids Health Dis. 10 2011 46
7. J. Liu, H. Zhang, Z. Li, T.K. Hailemariam, M. Chakraborty, K. Jiang, D. Qiu, H.H. Bui, D.A. Peake, M.S. Kuo, R. Wadgaonkar, S. Cao, and X.C. Jiang Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice Arterioscler. Thromb. Vasc. Biol. 29 2009 850 856
8. T.K. Hailemariam, C. Huan, J. Liu, Z. Li, C. Roman, M. Kalbfeisch, H.H. Bui, D.A. Peake, M.S. Kuo, G. Cao, R. Wadgaonkar, and X.C. Jiang Sphingomyelin synthase 2 deficiency attenuates NF κB activation Arterioscler. Thromb. Vasc. Biol. 28 2008 1519 1526
9. Z. Li, H. Zhang, J. Liu, C.P. Liang, Y. Li, Y. Li, G. Teitelman, T. Beyer, H.H. Bui, D.A. Peake, Y. Zhang, P.E. Sanders, M.S. Kuo, T.S. Park, G. Cao, and X.C. Jiang Reducing plasma membrane sphingomyelin increases insulin sensitivity Mol. Cell. Biol. 31 2011 4205 4218
10. S. Mitsutake, K. Zama, H. Yokota, T. Yoshida, M. Tanaka, M. Mitsui, M. Ikawa, M. Okabe, Y. Tanaka, T. Yamashita, H. Takemoto, T. Okazaki, T. Watanabe, and Y. Igarashi Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes J. Biol. Chem. 286 2011 28544 28555
11. M. Yano Mitochondrial dysfunction and increased reactive oxygen species impair insulin secretion in sphingomyelin synthase 1-null mice J. Biol. Chem. 286 2011 3992 4002
12. A. Meng, C. Luberto, P. Meier, A. Bai, X. Yang, Y.A. Hannun, and D. Zhou Sphingomyelin synthase as a potential target for D609-induced apoptosis in U937 human monocytic leukemia cells Exp. Cell Res. 292 2004 385 392